Modification of hepatitis b core antigen

Details for Australian Patent Application No. 2001266163 (hide)

Owner Celltech Pharmaceticals Limited

Inventors Pumpens, Paul; Borisova, Galina; Page, Mark; Li, Jingli

Agent Blake Dawson Waldron

Pub. Number AU-B-2001266163

PCT Pub. Number WO01/98333

Priority 0024544 06.10.00 GB; 0015308 22.06.00 GB

Filing date 22 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 13 July 2006

International Classifications

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

13 July 2006 Application Accepted

  Published as AU-B-2001266163

16 November 2006 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001266165

2001266162